Cargando…
MicroRNA-584 Impairs Cellular Proliferation and Sensitizes Osteosarcoma Cells to Cisplatin and Taxanes by Targeting CCN2
BACKGROUND: Osteosarcoma (OS), an aggressive malignant neoplasm, exhibits osteoblastic differentiation. Cisplatin (DDP) and taxanes are among the most effective drugs for OS patients. Nevertheless, the drug resistance remains a main limitation to efficacious chemotherapy in OS. The current report se...
Autores principales: | Li, Li, Kong, Xiang’an, Zang, Mousheng, Hu, Bin, Fang, Xing, Gui, Binjie, Hu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167371/ https://www.ncbi.nlm.nih.gov/pubmed/32346311 http://dx.doi.org/10.2147/CMAR.S246545 |
Ejemplares similares
-
Hsa_circ_0003732 promotes osteosarcoma cells proliferation via miR-545/CCNA2 axis
por: Li, Li, et al.
Publicado: (2020) -
CCN2 Enhances Resistance to Cisplatin-Mediating Cell Apoptosis in Human Osteosarcoma
por: Tsai, Hsiao-Chi, et al.
Publicado: (2014) -
SUN-584 Micrornas in Brown and White Adipocytes
por: Dimitri, Federica, et al.
Publicado: (2020) -
MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin
por: Patil, Sagar L., et al.
Publicado: (2019) -
MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells
por: Vanas, Vanita, et al.
Publicado: (2016)